{"id":451418,"date":"2024-01-04T10:37:31","date_gmt":"2024-01-04T15:37:31","guid":{"rendered":"https:\/\/platohealth.ai\/eric-perreault-new-kiyatec-ceo-to-lead-strategic-expansion-medical-device-news-magazine\/"},"modified":"2024-01-04T12:09:34","modified_gmt":"2024-01-04T17:09:34","slug":"eric-perreault-new-kiyatec-ceo-to-lead-strategic-expansion-medical-device-news-magazine","status":"publish","type":"post","link":"https:\/\/platohealth.ai\/eric-perreault-new-kiyatec-ceo-to-lead-strategic-expansion-medical-device-news-magazine\/","title":{"rendered":"Eric Perreault New Kiyatec CEO To Lead Strategic Expansion – Medical Device News Magazine","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"
<\/div>\n
\n

Kiyatec<\/h2>\n

Kiyatec, a leading biotechnology company specializing in 3D cell culture technology, is pleased to announce the promotion of Eric Perreault to the position of chief executive officer (CEO).<\/h4>\n

Eric Perreault Role<\/h2>\n

As CEO, Eric Perreault will continue to lead Kiyatec in its mission to revolutionize cancer care by harnessing the power of functional precision medicine with its KIYA-Predict\u2122 and 3D Predict\u2122 platforms. He succeeds Matt Gevaert, PhD, who after more than 15 years as CEO will remain a member of Kiyatec\u2019s Board of Directors.<\/p>\n

\u201cWe are excited to announce Eric Perreault as the new CEO of Kiyatec. Eric\u2019s leadership and extensive understanding of both our technology and industry are assets that will drive Kiyatec\u2019s continued growth. We\u2019re confident that, under Eric\u2019s guidance, Kiyatec will make a meaningful and enduring contribution to cancer treatment and drug discovery.\u201d<\/p>\n

As President of Kiyatec, Eric has been an integral part of the Kiyatec team and has played a crucial role in shaping the company\u2019s strategic direction. With his extensive industry experience and leadership acumen, Eric\u2019s promotion to CEO marks a significant milestone in Kiyatec\u2019s journey. In this new position, Eric will propel Kiyatec toward commercial success by driving innovation, forging strategic partnerships, and expanding market reach.<\/p>\n

Eric Perreault on His New Role<\/h2>\n

\u201cIn my new role as CEO, my mission is to drive Kiyatec toward truly revolutionizing cancer care, especially for patients battling brain cancer, who haven\u2019t seen any real treatment advances in decades,\u201d said Eric. \u201cI\u2019m eager to continue collaborating with Matt as a member of our board and tapping into his extensive experience to propel us toward accomplishing this ambitious goal.\u201d<\/p>\n

As Kiyatec<\/a> prepares for its next phase of growth and expansion, the company remains focused on advancing functional precision oncology with its 3D cell culture technology. With Eric Perreault as CEO, Kiyatec is well-positioned to spearhead transformative change in cancer care, ultimately driving improvements in patient outcomes.<\/p>\n<\/div>\n